Literature DB >> 11181517

Physiological concentrations of insulin promote binding of nuclear proteins to the insulin-like growth factor I gene.

E N Kaytor1, J L Zhu, C I Pao, L S Phillips.   

Abstract

Limitations in understanding the mechanism of transcriptional regulation by insulin are due in part to lack of models in which there is insulin-responsive binding of nuclear factors to critical promoter regions. The insulin-like growth factor I (IGF-I) gene responds to diabetes status via a footprinted sequence, region V, which contains an AT-rich element and a GC-rich site. We tested the hypothesis that insulin regulates nuclear factor binding to the AT-rich site. Gel shift analysis with liver nuclear extracts and a region V probe showed binding of Sp1, Sp3, and B(1), which persisted despite the presence of antibodies against Sp1 and Sp3. B(1) was detected by a probe mutated in the GC-rich site (VmSp1), but not by a probe mutated at the AT-rich site (VmAT). We then asked whether B(1) was responsive to insulin. For both region V and VmSp1 probes, nuclear extracts from normal rat hepatocytes, H4IIE cells, and CHO-IR cells exposed to 10(-6) M insulin exhibited an increase in binding, designated insulin-responsive binding protein (IRBP); IRBP comigrated with B(1) from liver extracts. IRBP binding to region V was competed by VmSp1, but not by VmAT, indicating specific interactions with the AT-rich sequence; insulin response elements from other genes also failed to compete. After addition of insulin, IRBP began to increase by 1 h and rose further at 24 h, suggesting involvement of both posttranslational and transcriptional mechanisms. IRBP responded to as little as 10(-10) M insulin, indicating physiological relevance. Induction of IRBP was blunted by the phosphatidylinositol 3'-kinase inhibitor LY294002, whereas other signal transduction inhibitors had little effect. IRBP interacts with an important sequence in the IGF-I gene and may participate in the metabolic regulation of IGF-I expression. As most insulin-responsive genes do not exhibit insulin-responsive nuclear factor binding, further studies of IRBP may also contribute to understanding of the mechanism of insulin action on gene transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181517     DOI: 10.1210/endo.142.3.8046

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

Review 1.  The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue.

Authors:  Gwang-Woong Go; Roshni Srivastava; Antonio Hernandez-Ono; Gyoungok Gang; Stephen B Smith; Carmen J Booth; Henry N Ginsberg; Arya Mani
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

2.  Regulation of insulin-response element binding protein-1 in obesity and diabetes: potential role in impaired insulin-induced gene transcription.

Authors:  Jaspreet Chahal; Ching-Chu Chen; Madhavi J Rane; Joseph P Moore; Michelle T Barati; Ying Song; Betty C Villafuerte
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

3.  Expression of liver insulin-like growth factor 1 gene and its serum level in patients with diabetes.

Authors:  Jian-Bo Li; Cheng-Ya Wang; Jia-Wei Chen; Zhen-Qing Feng; Hong-Tai Ma
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.